On September 3, 2026, Zhu Zhongyuan bought 10,000 shares of DUALITYBIO-B (09606) stock at an average of HKD 184.149 per share, involving about HKD 1.84 million.
Prior to the acquisition, Zhu Zhongyuan's long position in DUALITYBIO-B was 16.03 million shares, representing 17.56%; following the acquisition, the holding changed to 16.04 million shares, with the long position ratio rising to 17.58%.